Related Experiment Video

Updated: May 17, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Determinants of coronary collateral circulation in patients with coronary artery disease

Cafer Zorkun1, Emre Akkaya, Ali Zorlu

  • 1Clinic of Cardiology, Yedikule Thoracic Diseases and Surgery, Education and Research Hospital, İstanbul-Turkey. dremre_akkaya@hotmail.com

Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology
|November 7, 2012
PubMed

Insights

Male gender, prior statin use, and higher high-sensitive C-reactive protein (hs-CRP) levels are key determinants for developing coronary collaterals in severe coronary artery disease patients. These factors influence the formation of vital blood vessel networks.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Biomarkers in Cardiovascular Disease

Background:

  • Coronary artery disease (CAD) is a leading cause of mortality worldwide.
  • Development of coronary collaterals is crucial for myocardial perfusion in severe CAD.
  • Determinants of collateral formation in CAD remain incompletely understood.

Purpose of the Study:

  • To identify independent predictors of adequate coronary collateral vessel development in patients with severe coronary artery disease.
  • To investigate the association of demographic, clinical, and laboratory factors with coronary collateralization.

Main Methods:

  • Retrospective cohort study of 74 patients with severe left anterior descending artery stenosis or occlusion.
  • Assessment of coronary collateral grades, hs-CRP, lipids, and other biomarkers.
  • Multivariate logistic regression analysis to determine independent predictors of collateral development.

Main Results:

  • Higher prevalence of coronary collaterals observed in males, patients with elevated hs-CRP, prior statin use, and higher Gensini scores.
  • Independent predictors for adequate coronary collaterals included male gender (OR=4.73), prior statin usage (OR=4.70), and hs-CRP levels (OR=0.94).

Conclusions:

  • Male gender, prior statin therapy, and elevated hs-CRP levels are significant independent determinants of coronary collateral development in severe CAD.
  • These findings highlight potential therapeutic targets and patient subgroups for improved collateralization strategies.
Abstract

More Related Videos

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...